0000000001003586

AUTHOR

F. Reccardini

showing 1 related works from this author

Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common …

2019

OncologyAdultMalemedicine.medical_specialtyMEDLINEYoung AdultText miningInternal medicinemedicineImmunology and AllergyHumansImmunologic FactorsSingle agentIn patientYoung adultbusiness.industryCommon variable immunodeficiencyInterstitial lung diseasemedicine.diseaseRespiratory Function TestsCommon Variable ImmunodeficiencyTreatment OutcomeRituximabFemalebusinessLung Diseases InterstitialRituximabmedicine.drugThe journal of allergy and clinical immunology. In practice
researchProduct